Treating Cancer With Precision
All Clinical Trials
Oral Cavity Cancer
About Alpha Tau
News & Blog
Scientific Advisory Board
Board of Directors
Subscribe to our newsletter
In the Media
How Israeli technology saved 78-year-old Leah from skin cancer
Alpha-emitting Radiation Therapy Could Create a Paradigm Shift in Cancer Treatment
Alpha DaRT treatment proves a success in first-in-human trial
Israel's alpha radiation treatment shows tumor shrinkage in 100% of cases
Newsletter - Issue no. 4
Alpha Tau Announces the Publication of Exceptional Clinical Data from Alpha DaRT, its Novel Alpha Ra
Israeli MedTech Start-up, Alpha Tau Medical, Raises $29 Million in Private Financing to Cure Cancer
Alpha Tau’s High-Precision Cancer Radiotherapy Receives Radioactive-Safety Approval in the United St
First Alpha Tau Medical Summit Gathers Over 200 Oncologists and Physicians From all Around the World
5 days ago
Meet Alpha Tau at ESTRO 2021
We are pleased to take part in The European Society for Radiotherapy and Oncology (ESTRO)'s annual congress that will be held in Madrid,...
Alpha Tau & Healthcare Capital Corp. to Combine and Create A $1-Billion Publicly Traded Company
Alpha Tau and Healthcare Capital Corp. to Combine and Create A Publicly Traded Company Focused on Transforming the Treatment of Solid...
First Alpha DaRT Patient Treated in the US as Part of Pilot Multicenter Skin Cancer Trial
Jerusalem, Israel, July 6, 2021 - Alpha Tau Medical, the developer of the pioneering alpha-radiation cancer therapy Alpha DaRTTM,...
Alpha Tau Receives Breakthrough Device Designation from the FDA for Alpha DaRT™
JERUSALEM, June 8, 2021 /PRNewswire/ -- Alpha Tau Medical, the developer of the pioneering alpha-radiation cancer therapy Alpha DaRT,TM...